What is myelom?

myeloma is a condition in which plasma cells, cells in the bone marrow that produce antibodies, become cancer. Sometimes it is referred to as dyscrasia of plasma cells or myeloma of plasma cells and most often as multiple myeloma (mm) . Multiple myeloma is the most common form found in patients and is named because it includes more places in the body. Cells begin to grow at uncontrollable speed and develop on tumors in many places. However, a small percentage of patients develop these cells outside the bone marrow and others have lonely myeloma, which means that the disease affects only one area. The pain usually deteriorates by movement. Other common symptoms include chronic or acute infections, anemia and kidney failure. Myeloma, however, is so diverse in its work and development that the symptoms can be equally diverse. Increased levels of paraprotein and calcium are laboratory indicators. If myeloma is suspected, further diagnostics including skeletal scanningSurvey or computer tomography (CT) along with bone marrow biopsy. The method of diagnosis depends on the attending physician.

The prognosis for myeloma is usually not good. Although there is currently no treatment, treatment is an option. Treatment revolves around disease retention and suppression of symptoms and disease progression.

Basic symptoms, including anemia and kidney failure, if present, must be treated first. Steroids and chemotherapy are standard treatment options for myeloma. In some cases, stem cell transplantation is proposed treatment.

Most patients who were treated for this condition and at some point have achieved a relapse of clinical remission. According to the international performance system (ISS) for myeloma, the middle prognosis of survival for 1 62 months is, 2 is 49 months and 3 is 29 months.